CINECA IRIS Institutional Research Information System

DI RENZO, Maria Flavia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.739
EU - Europa 3.116
AS - Asia 1.363
AF - Africa 39
OC - Oceania 15
SA - Sud America 5
Totale 9.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.623
CN - Cina 880
IT - Italia 468
IE - Irlanda 460
SE - Svezia 437
UA - Ucraina 341
DE - Germania 324
FR - Francia 295
FI - Finlandia 278
KR - Corea 242
GB - Regno Unito 224
CA - Canada 114
AT - Austria 111
PL - Polonia 99
VN - Vietnam 73
IN - India 51
SG - Singapore 46
BE - Belgio 32
SN - Senegal 32
JP - Giappone 25
TW - Taiwan 18
AU - Australia 15
NL - Olanda 14
RU - Federazione Russa 11
ES - Italia 7
RO - Romania 7
UZ - Uzbekistan 5
HK - Hong Kong 4
IR - Iran 4
NG - Nigeria 4
TR - Turchia 4
BG - Bulgaria 3
CL - Cile 3
PK - Pakistan 3
CH - Svizzera 2
MU - Mauritius 2
MX - Messico 2
MY - Malesia 2
TH - Thailandia 2
BD - Bangladesh 1
BR - Brasile 1
BY - Bielorussia 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 9.277
Salva come PNG Salva come JPEG
Città #
Chandler 816
Beijing 630
Dublin 460
Houston 288
Ann Arbor 269
Fairfield 225
Jacksonville 217
Ashburn 207
Medford 175
Princeton 169
Villeurbanne 168
Dearborn 166
Woodbridge 163
Nyköping 133
Wilmington 126
Vienna 109
Torino 98
Warsaw 92
Milan 89
Seattle 85
Cambridge 72
Toronto 70
Boston 57
Boardman 52
Dong Ket 50
Verona 47
Pisa 46
Fremont 44
Brussels 30
New York 30
Hefei 28
Munich 27
Lachine 26
Norwalk 24
Kunming 22
Nanjing 22
Turin 22
Falls Church 21
Redwood City 20
Washington 17
Guangzhou 16
Shanghai 15
Taipei 14
Jinan 13
Mangalore 13
Nanchang 13
Silver Spring 13
San Diego 12
Ottawa 11
Pune 11
Auburn Hills 10
Hangzhou 9
Tappahannock 9
Wuhan 9
Düsseldorf 8
Hebei 8
Tokyo 8
Xian 8
Buffalo 7
Dallas 7
Mountain View 7
Paris 7
Phoenix 7
Tsukishima 7
Turku 7
Zhengzhou 7
Los Angeles 6
Rome 6
Utrecht 6
Chengdu 5
Redmond 5
Shenyang 5
Singapore 5
Abuja 4
Carrara 4
Florence 4
Fuzhou 4
Menlo Park 4
Savigliano 4
Shenzhen 4
Udine 4
Amsterdam 3
Beinasco 3
Bengaluru 3
Berlin 3
Changsha 3
Grafing 3
Helsinki 3
Lodi 3
Montréal 3
Nürnberg 3
Polska 3
Santiago 3
Seoul 3
Sofia 3
Acton 2
Alameda 2
Andezeno 2
Charleston 2
Chennai 2
Totale 5.790
Salva come PNG Salva come JPEG
Nome #
PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy 318
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 216
A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging 185
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas 159
Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 144
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer. 144
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. 139
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. 137
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2. 132
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. 124
Amplification of repeat-containing transcribed sequences (ARTS): a transcriptome fingerprinting strategy to detect functionally relevant microsatellite mutations in cancer. 117
Biosynthesis of the protein encoded by the c-met proto-oncogene 116
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers 115
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 115
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells 107
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase. 106
Atlante di Istologia e Anatomia Microscopica 104
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 103
[Molecular markers study in pTNM of squamous carcinoma of the head and neck] 102
A cancer-predisposing "hot spot" mutation of the fumarase gene creates a dominant negative protein 99
Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin 97
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF 95
Sparsely-connected autoencoder (SCA) for single cell RNAseq data mining 95
Deletion in a (T)8 microsatellite abrogates expression regulation by 3'-UTR. 93
A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth 92
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma 89
Characterization of T lymphocytes mediating in vivo protection against RSV-induced murine sarcomas. 88
IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness. 88
Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1. 87
The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo 86
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C 85
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism. 85
Monoclonal antibodies to the collagen binding domain of human plasma fibronectin. 82
Tyrosine kinase receptor indistinguishable from the c-met protein. 81
Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism 81
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions 80
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C 78
[Tyrosine-phosphorylated proteins in human breast carcinoma] 76
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression 76
Immunofluorescence study of fibronectin distribution in the developing chick embryo striated muscles. 75
Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation 75
Proteins phosphorylated on tyrosine as markers of human tumor cell lines 73
Control of invasive growth by the HGF receptor family. 72
Altered regulation of receptor associated-tyrosine kinases in human tumors 72
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer 72
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. 71
The c-met/HGF receptor in human tumours. 71
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway 71
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. 71
Tyrosine kinase and control of cell proliferation 70
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS 68
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications. 68
Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line. 68
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 67
Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. 66
Overexpression of the met/HGF receptor in renal cell carcinomas. 65
p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis 65
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling 64
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 63
Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts 62
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. 62
Cells lacking fumarase are protected from apoptosis through a HIF independent, AMPK dependent mechanism 61
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis 61
Expression of Hepatocyte Growth Factor (HGF) and its Receptor (MET) in Medullary Carcinoma of the Thyroid. 60
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin 60
Detection of phosphotyrosine-containing proteins in the detergent-insoluble fraction of RSV-transformed fibroblasts by azobenzene phosphonate antibodies. 59
Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein. 59
Selective expression of the Met/HGF receptor in human central nervous system microglia 59
Characterization of stable spontaneous metastatic variant lines of RSV-transformed mouse fibroblasts. 58
LE PROPRIETÀ ONCOSOPPRESSIVE INTRINSECHE DELL’ONCOGENE MET COME STRUMENTO DI MORTE APOPTOTICA DELLE CELLULE TUMORALI 58
Overexpression of the RON gene in human breast carcinoma 57
Patient-derived cancer models 57
Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. 56
p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line. 56
MET receptor is overexpressed but not mutated in oral squamous cell carcinomas 55
Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin 55
Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion 55
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer 55
The MET-oncogene transforms human primary cultures of bone-derived cells by targeting osteo-progenitors. 55
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs 55
[Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors] 54
Role of heterochromatin variation in the instability of a marker chromosome during tumor progression 54
Organization of cytoskeleton and fibronectin matrix in Rous sarcoma virus (RSV)-transformed fibroblast lines with different metastatic potential. 54
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. 54
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 54
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel 54
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 53
Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity. 52
p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis 52
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. 51
Genetics in renal cancer 51
MET overexpression turns human primary osteoblasts into osteosarcomas 51
Thermal behavior of high silica mordenite 50
Protein tyrosine kinases associated with human malignancies 49
High chemotactic motility and growth in hard agar of a variant of RSV-transformed fibroblasts are lost in late passages 48
Lipid characteristics of RSV-transformed Balb/c 3T3 cell lines with different spontaneous metastatic potentials 48
Metastatic clones selected from an RSV-induced mouse sarcoma share a common marker chromosome. 47
Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis 47
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex 47
Immunological detection of proteins phosphorylated at tyrosine in cells stimulated by growth factors or transformed by retroviral-oncogene-coded tyrosine kinases 47
Totale 8.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.151
article - articoli 0
book - libri 0
conference - conferenze 4.341
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019340 0 0 0 0 0 0 0 0 0 107 170 63
2019/20201.351 38 33 84 120 116 273 195 67 144 135 94 52
2020/20211.060 116 47 87 53 84 45 133 53 141 105 53 143
2021/20221.331 34 48 56 78 47 50 105 65 35 92 320 401
2022/20232.144 271 174 89 204 191 525 161 119 218 28 103 61
2023/2024633 123 148 39 47 35 144 28 43 5 21 0 0
Totale 9.642